Acute infections as a means of cancer prevention: Opposing effects to chronic infections?

Cancer Detection and Prevention

Volumn 30, Issue 1, 2006, Pages 83-93

  Hoption Cann, Stephen A ^a   Van Netten, J P ^b   Van Netten, C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF VICTORIA   (Canada)

Author keywords

Cancer prevention; Fever; Infection; Leukocytes; Spontaneous regression

Indexed keywords

ACETYLSALICYLIC ACID; ANTIPYRETIC AGENT; BACTERIAL VACCINE; BCG VACCINE; CHEMOKINE RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; VACCINIA VACCINE;

CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER INHIBITION; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; DISEASE ASSOCIATION; DRUG INHIBITION; FEVER; GLIOMA; HUMAN; IMMUNE RESPONSE; INFECTION; INFLAMMATORY CELL; MACROPHAGE; MELANOMA; MENINGIOMA; MULTIPLE CANCER; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SOCIOECONOMICS; TUMOR GROWTH;

EID: 33644900270     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2005.11.001     Document Type: Short Survey

References (142)

1. Accessed June 1, 2005: http://www.who.int/vaccine_research/en/.
2. R. Pearl Cancer and tuberculosis Am J Hygiene 9 1929 97 159
3. L.M. Prescott, J.P. Harley, and D.A. Klein Microbiology 2nd ed. 1993 Wm C Brown Dubuque, IO p. 393
4. A.L. Gregson, and P.A. Mackowiak Pathogenesis of fever J. Cohen W.G. Powderly Infectious diseases 2nd ed. 2004 Mosby New York 853
5. S.A. Hoption Cann, J.P. van Netten, C. van Netten, and D.W. Glover Spontaneous regression: a hidden treasure buried in time Med Hypotheses 58 2002 115 119
6. S.A. Hoption Cann, J.P. van Netten, and C. van Netten Dr William Coley and tumour regression: a place in history or in the future? Postgraduate Med J 79 2003 672 680
7. S.A. Hoption Cann, H.D. Gunn, J.P. van Netten, and C. van Netten Spontaneous regression of pancreatic cancer Case Rep Clin Prac Rev 5 2004 293 296
8. G. Dupuytren De la gangrène spontanée géné rale et partielle des tumeurs cancéreuses du sein J Hebdom Med 4 1829 38 41
9. W.B. Coley Treatment of inoperable malignant tumors with toxins of erysipelas and the bacillus prodigiosus Trans Am Surg Assoc 12 1894 183 212
10. H.C. Nauts, G.A. Fowler, and F.H. Bogatko A review of the influence of bacterial infection and of bacterial products (Coley's toxins) on malignant tumors in man Acta Med Scand Suppl 276 1953 1 103
11. W.B. Coley The therapeutic value of the mixed toxins of the streptococcus of erysipelas and Bacillus prodigiosis in the treatment of inoperable malignant tumors, with a report of 160 cases Am J Med Sci 112 1896 251 281
12. H.C. Nauts Bibliography of reports concerning the clinical or experimental use of Coley toxins 1982 Cancer Research Institute New York p. 1-23
13. A. Didot Prophylaxie du cancer par la syphilization Presse Med 4 1852 117-9, 143-5
14. J.Z. Laurence The diagnosis of surgical cancer 2nd ed. 1858 Churchill London p. 56
15. E. Lambotte Contribution a la pathogénie du cancer. Antécédents purulents des cancéreux. Enquete sur 30 cas Presse Med Belge 48 1896 161-5, 273-4
16. M. Soegaard Die relative Krebsimmunitat der Leprakranken Berlin Klin Wochenschr 48 1911 1718 1722
17. W. Kobayashi Extreme rarity of cancer in patients with leprosy Acta Dermatol 10 1927 441 447
18. Voussoughi D. Amibiase intestinale pséudo-neoplastique, No. 750. Thèse de Paris; 1946.
19. J. Baecker Ueber Aetiologie und Therapie des Gebërmutterkrebses Arch Gynakol 53 1897 46 91
20. A. Didot Essai sur la prophylaxie du cancer par la syphilization artificielle Bull Acad Roy Belge 11 1851-1852 100 172
21. F. Loeffler Einer neue Behandlungsmethode des Karzinoms Deutsche Med Wochenschr 27 1901 725 726
22. S.S. Davidson Carcinoma and malaria Br Med J 1 1902 77
23. A. Mori Carcinosi e malaria Clin Med Pisa 8 1902 158 162
24. A. Rovighi Krebs und malaria Z Krebsforsch 3 1905 604
25. W.M. Dabney Tuberculosis and cancer. A possible explanation of the long-discussed question of their mutual antagonism with the suggestion of the use of tuberculin for the prevention of recurrence of cancer Med Rec 90 1916 804 805
26. S.W. Tromp Possible counteracting influence of tuberculosis on development of cancer in The Netherlands Am J Clin Pathol 34 1954 35 38
27. D.R. Haldane The co-existence of tubercle and cancer Edinburgh Med J 8 1862 343 349
28. I. Levin Cancer among North American Indians and its bearing upon the ethnological distribution of the disease W.H. Woglom Studies in cancer and allied subjects vol. 2 1912 Columbia University New York 57
29. R.L. Smith, C.G. Salsbury, and A.G. Gilliam Recorded and expected mortality among Navajo, with special reference to cancer J Natl Cancer Inst 17 1956 77 89
30. R.L. Smith Recorded and expected mortality among Indians of the United States with special reference to cancer J Natl Cancer Inst 18 1957 385 396
31. F.L. Hoffman The mortality from cancer in the Western hemisphere J Cancer Res 1 1916 21 48
32. Anonymous Erysipelas and prodigiosus toxins (Coley) JAMA 103 1934 1070 1071
33. C. Jacobsen Chronic irritation of reticulo-endothelial system a hindrance to cancer Arch Dermatol Syph 169 1934 562 576
34. R. Schmidt Krebs and Infektionskrankheiten Med Klin 62 1910 1690 1693
35. P. Engel Uber den Infektionsindex der Krebskranken Wien Klin Wochenschr 47 1934 1118 1119
36. P. Engel Uber den Einfluss des Alters auf den Infektionsindex der Krebskranken Wien Klin Wochenschr 48 1935 112 113
37. F. Sinek Versuch einer statistchen Erfassung endogener Faktoren bei Carcinomerkrankungen Z Krebsforsch 44 1936 492 527
38. F.H. Ungar Pirquet's theory of allergy and the problem of malignant tumors Medizinische 47 1954 1563 1565
39. E. Kofler, and M. Hussarek Constitutional factors in rhinitis vasomotoria, nasal polypi and nasal carcinoma Krebsarzt 9 1954 89 94
40. G. Mastrangelo, E. Fadda, and G. Milan Cancer increased after a reduction of infections in the first half of this century in Italy: etiologic and preventive implications Eur J Epidemiol 14 1998 749 754
41. E. Pukkala, and E. Weiderpass Time trends in socio-economic differences in incidence rates of cancers of the breast and female genital organs (Finland, 1971-1995) Int J Cancer 81 1999 56 61
42. C. Bouchardy, G. Schuler, and C. Minder Cancer risk by occupation and socioeconomic group among men - a study by the Association of Swiss Cancer Registries Scand J Work Environ Health 28 Suppl 1 2002 1 88
43. K. Hemminki, H. Zhang, and K. Czene Socioeconomic factors in cancer in Sweden Int J Cancer 105 2003 692 700
44. H.F. Eichenwald, and G.H. McCracken Jr. Acute diarrheal disease Med Clin N Am 54 1970 443 454
45. P. Glezen, and F.W. Denny Epidemiology of acute lower respiratory disease in children N Engl J Med 288 1973 498 505
46. N.M. Graham The epidemiology of acute respiratory infections in children and adults: a global perspective Epidemiol Rev 12 1990 149 178
47. G. Borgnolo, F. Barbone, G. Scornavacca, D. Franco, A. Vinci, and F. Iuculano A case-control study of Salmonella gastrointestinal infection in Italian children Acta Paediatr 85 1996 804 808
48. J. Garcia Epidemiology of acute bronchopulmonary infections in children Rev Prat 46 1996 2056 2061
49. J.C. Butler, and A. Schuchat Epidemiology of pneumococcal infections in the elderly Drugs Aging 15 Suppl 1 1999 11 19
50. J.M. Stuart, N. Middleton, and D.J. Gunnell Socioeconomic inequality and meningococcal disease Commun Dis Public Health 5 2002 327 328
51. S. Parikh, P. Brennan, and P. Boffetta Meta-analysis of social inequality and the risk of cervical cancer Int J Cancer 105 2003 687 691
52. A. Bener, S.A. Uduman, and A. Ameen Prevalence of Helicobacter pylori infection among low socio-economic workers J Commun Dis 34 2002 179 184
53. S.K. Chong, Q. Lou, and T.W. Zollinger The seroprevalence of Helicobacter pylori in a referral population of children in the United States Am J Gastroenterol 98 2003 2162 2168
54. S.O. Stuver, C. Boschi-Pinto, and D. Trichopoulos Infection with hepatitis B and C viruses, social class and cancer IARC Sci Publ 138 1997 319 324
55. R.O. West Epidemiologic study of malignancies of the ovaries Cancer 19 1966 1001 1007
56. M.L. Newhouse, R.M. Pearson, J.M. Fullerton, E.A. Boesen, and H.S. Shannon A case control study of carcinoma of the ovary Br J Prev Soc Med 31 1977 148 153
57. U. Abel, N. Becker, and R. Angerer Common infections in the history of cancer patients and controls J Cancer Res Clin Oncol 117 1991 339 344
58. K.F. Kolmel, O. Gefeller, and B. Haferkamp Febrile infections and malignant melanoma: results of a case-control study Melanoma Res 2 1992 207 211
59. H.U. Albonico, H.U. Braker, and J. Husler Febrile infectious childhood diseases in the history of cancer patients and matched controls Med Hypotheses 51 1998 315 320
60. C. Hoffmann, A. Rosenberger, W. Troger, and M. Buhring Childhood diseases, infectious diseases, and fever as potential risk factors for cancer? Forsch Komplementarmed Klass Naturheilkd 9 2002 324 330
61. A. Remy, K. Hammerschmid, K.S. Zanker, L. Ulm, W. Theisinger, and J.R. Siewert Lower frequency of infections in cancer patients: do infections protect against cancer? J Exp Clin Cancer Res 2 1983 49 51
62. C. Chilvers, B. Johnson, S. Leach, C. Taylor, and E. Vigar The common cold, allergy, and cancer Br J Cancer 54 1986 123 126
63. R. Grossarth-Maticek, R. Frentzel-Beyme, D. Kanazir, M. Jankovic, and H. Vetter Reported herpes-virus-infection, fever and cancer incidence in a prospective study J Chronic Dis 40 1987 967 976
64. B. Schlehofer, M. Blettner, and S. Preston-Martin Role of medical history in brain tumour development. Results from the international adult brain tumour study Int J Cancer 82 1999 155 160
65. K.F. Kolmel, A. Pfahlberg, and G. Mastrangelo Infections and melanoma risk: results of a multicentre EORTC case-control study. European Organization for Research and Treatment of Cancer Melanoma Res 9 1999 511 519
66. H.C. Nauts The beneficial effects of bacterial infections on host resistance to cancer: end results in 449 cases 2nd ed. 1980 Cancer Research Institute New York [Monograph No. 8.]
67. V. Lopes, L.S. Young, and P.G. Murray Epstein-Barr virus-associated cancers: aetiology and treatment Herpes 10 2003 78 82
68. M. Omata, and H. Yoshida Prevention and treatment of hepatocellular carcinoma Liver Transpl 10 2004 S111 S114
69. M. Fiorilli, C. Mecucci, P. Farci, and M. Casato HCV-associated lymphomas Rev Clin Exp Hematol 7 2003 406 423
70. U.R. Hengge, T. Ruzicka, and S.K. Tyring Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2. Pathogenesis, Castleman's disease, and pleural effusion lymphoma Lancet Infect Dis 2 2002 344 352
71. C. Bellan, G. De Falco, S. Lazzi, and L. Leoncini Pathologic aspects of AIDS malignancies Oncogene 22 2003 6639 6645
72. M. Melbye, E.I. Svare, S.K. Kjaer, and M. Frisch Human papillomavirus and the risk of anogenital cancer Ugeskr Laeger 164 2002 5950 5953
73. B.J. Poiesz, M.J. Poiesz, and D. Choi The human T-cell lymphoma/leukemia viruses Cancer Invest 21 2003 253 277
74. S.A. Hoption Cann, J.P. van Netten, and C. van Netten MALT lymphomas and Helicobacter pylori? Gut 48 2001 283 284
75. G. Nardone, and A. Morgner Helicobacter pylori and gastric malignancies Helicobacter 1 8 Suppl 2003 44 52
76. C.P. Caygill, M.J. Hill, M. Braddick, and J.C. Sharp Cancer mortality in chronic typhoid and paratyphoid carriers Lancet 343 1994 83 84
77. S.L. Johansson, and S.M. Cohen Epidemiology and etiology of bladder cancer Semin Surg Oncol 13 1997 291 298
78. A. Ishii, H. Matsuoka, and N. Ohta Parasite infection and cancer: with special emphasis on Schistosoma japonicum infections (Trematoda) Mutat Res 305 1994 273 281
79. P. Watanapa, and W.B. Watanapa Liver fluke-associated cholangiocarcinoma Br J Surg 89 2002 962 970
80. A.J. Lax, and W. Thomas How bacteria could cause cancer: one step at a time Trends Microbiol 10 2002 293 299
81. B. Sripa Pathobiology of opisthorchiasis: an update Acta Trop 88 2003 209 220
82. E. Szabo, C. Paska, P. Kaposi Novak, Z. Schaff, and A. Kiss Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis Pathol Oncol Res 10 2004 5 11
83. S.A. Weitzman, A.B. Weitberg, E.P. Clark, and T.P. Stossel Phagocytes as carcinogens: malignant transformation produced by human neutrophils Science 227 1985 1231 1233
84. J.K. Sandhu, H.F. Privora, G. Wenckebach, and H.C. Birnboim Neutrophils, nitric oxide synthase, and mutations in the mutatect murine tumor model Am J Pathol 156 2000 509 518
85. H. Kataoka, H. Tanaka, K. Nagaike, S. Uchiyama, and H. Itoh Role of cancer cell-stroma interaction in invasive growth of cancer cells Hum Cell 16 2003 1 14
86. H. Tazawa, F. Okada, and T. Kobayashi Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression Am J Pathol 163 2003 2221 2232
87. A. Morgner, C. Thiede, and E. Bayerdorffer Long-term follow-up of gastric MALT lymphoma after H. pylori eradication Curr Gastroenterol Rep 3 2001 516 522
88. W.W. Ng, C.P. Lam, and W.K. Chau Regression of high-grade gastric mucosa-associated lymphoid tissue lymphoma with Helicobacter pylori after triple antibiotic therapy Gastrointest Endosc 51 2000 93 96
89. L.t. Chen, J.T. Lin, and R.Y. Shyu Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach J Clin Oncol 19 2001 4245 4251
90. A. Morgner, S. Miehlke, and W. Fischbach Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection J Clin Oncol 19 2001 2041 2048
91. W. Fischbach, W. Tacke, and A. Greiner Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori Lancet 349 1997 31 32
92. H. Nakase, K. Okazaki, and M. Ohana The possible involvement of micro-organisms other than Helicobacter pylori in the development of rectal MALT lymphoma in H. pylori-negative patients Endoscopy 34 2002 343 346
93. G. Caletti, T. Togliani, and P. Fusaroli Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy Gastroenterology 124 2003 537 543
94. R. Matsumoto, H. Mukai, A. Sano, M. Tokoshima, S. Kato, and T. Ii Case of pulmonary MALT lymphoma successfully treated with clarithromycin Jpn J Antibiot 54 Suppl C 2001 12 15
95. S. Gupte, R. Nair, and K.N. Naresh MALT lymphoma of nasal mucosa treated with antibiotics Leuk Lymphoma 36 1999 195 197
96. S. Alkan, D.S. Karcher, and M.A. Newman Regression of salivary gland MALT lymphoma after treatment for Helicobacter pylori Lancet 348 1996 268 269
97. D. Berrebi, B. Lescoeur, and A. Faye MALT lymphoma of labial minor salivary gland in a immunocompetent child with a gastric Helicobacter pylori infection J Pediatr 133 1998 290 292
98. L. Arcaini, M. Paulli, E. Boveri, U. Magrini, and M. Lazzarino Marginal zone-related neoplasms of splenic and nodal origin Haematologica 88 2003 80 93
99. N. Arima, and M. Tsudo Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy Br J Haematol 120 2003 790 792
100. A. Morgner, N. Lehn, and L.P. Andersen Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection Gastroenterology 118 2000 821 828
101. M. Lecuit, E. Abachin, and A. Martin Immunoproliferative small intestinal disease associated with Campylobacter jejuni N Engl J Med 350 2004 239 248
102. F. Inoue, and T. Chiba Regression of MALT lymphoma of the rectum after anti-H. pylori therapy in a patient negative for H. pylori Gastroenterology 117 1999 514 515
103. K. Saito, K. Arai, M. Mori, R. Kobayashi, and I. Ohki Effect of Helicobacter pylori eradication on malignant transformation of gastric adenoma Gastrointest Endosc 52 2000 27 32
104. R. Snoeck, G. Andrei, and E. De Clercq Cidofovir in the treatment of HPV-associated lesions Verh K Acad Geneeskd Belg 63 2001 93 120
105. S. Koonsaeng, C. Verschraegen, and R. Freedman Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir J Med Virol 64 2001 195 198
106. J.P. van Netten, B.J. Ashmead, and D. Cavers 'Macrophages' and their putative significance in human breast cancer Br J Cancer 66 1992 220 221
107. K.D. Elgert, D.G. Alleva, and D.W. Mullins Tumor-induced immune dysfunction: the macrophage connection J Leukoc Biol 64 1998 275 290
108. H.A. Horst, and H.P. Horny Frequency distribution of lymphoreticular infiltrates in invasive carcinoma of the female breast Cancer Detect Prev 11 1988 297 301
109. J.P. van Netten, E.J. George, B.J. Ashmead, C. Fletcher, I.G. Thorton, and P. Coy Macrophage-tumour cell associations in breast cancer Lancet 342 1993 872 873
110. G.T. Beatson On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases Lancet ii 1896 162 165
111. F.S. Jones, and P. Rous On the cause of localization of secondary tumors at points of injury J Exp Med 20 1914 404 412
112. P. Rous, and J.W. Beard A virus-induced mammalian growth with the characters of a tumour J Exp Med 60 1934 701 766
113. P. Rous, and J.W. Beard The progression to carcinoma of virus-induced rabbit papilloma J Exp Med 62 1935 523 548
114. A. Haddow Molecular repair, wound healing, and carcinogenesis: tumor production a possible overhealing? Adv Cancer Res 16 1972 181 234
115. G. Bellingan Leukocytes: friend or foe Intensive Care Med 26 2000 S111 S118
116. H.F. Dvorak Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing N Engl J Med 315 1986 1650 1659
117. G.F. Whalen Solid tumours and wounds: transformed cells misunderstood as injured tissue? Lancet 336 1990 1489 1492
118. A. Ben-Baruch Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions Breast Cancer Res 5 2003 31 36
119. S.C. Robinson, K.A. Scott, J.L. Wilson, R.G. Thompson, A.E. Proudfoot, and F.R. Balkwill A chemokine receptor antagonist inhibits experimental breast tumor growth Cancer Res 63 2003 8360 8365
120. J.W. Pollard Tumour-educated macrophages promote tumour progression and metastasis Nat Rev Cancer 4 2004 71 78
121. B. Bottazzi, N. Polentarutti, and R. Acero Regulation of the macrophage content of neoplasms by chemoattractants Science 220 1983 210 212
122. Hoption Cann SA. The immune system and breast carcinoma: implications of dietary and other associated factors. PhD Dissertation. Victoria, BC: University of Victoria; 2001.
123. S. Gordon Macrophages and the immune response W.E. Paul Fundamental immunology 4th ed. 1999 Lippincott-Raven Philadelphia 533 546
124. A. Schmeisser, C.D. Garlichs, and H. Zhang Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions Cardiovasc Res 49 2001 671 680
125. J. Rehman, J. Li, C.M. Orschell, and K.L. March Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors Circulation 107 2003 1164 1169
126. E.Y. Lin, A.V. Nguyen, R.G. Russell, and J.W. Pollard Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy J Exp Med 193 2001 727 740
127. A. Gabizon, S.J. Leibovich, and R. Goldman Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo J Natl Cancer Inst 65 1980 913 920
128. G. Poste, and R. Kirsh Rapid decay of tumoricidal activity and loss of responsiveness to lymphokines in inflammatory macrophages Cancer Res 39 1979 2582 2590
129. R. Keller, R. Keist, P. Joller, and A. Mulsch Coordinate up- and down-modulation of inducible nitric oxide synthase, nitric oxide production, and tumoricidal activity in rat bone-marrow-derived mononuclear phagocytes by lipopolysaccharide and gram-negative bacteria Biochem Biophys Res Commun 211 1995 183 189
130. R. Kleef, W.B. Jonas, W. Knogler, and W. Stenzinger Fever, cancer incidence and spontaneous remissions Neuroimmunomodulation 9 2001 55 64
131. M.J. Kluger Fever in acute disease - beneficial or harmful? Wien Klin Wochenschr 114 2002 73 75
132. L.A. Greisman, and P.A. Mackowiak Fever: beneficial and detrimental effects of antipyretics Curr Opin Infect Dis 15 2002 241 245
133. J.R. Ostberg, and E.A. Repasky Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function Cancer Immunol Immunother 55 2006 292 298
134. H. Hashizume, P. Baluk, and S. Morikawa Openings between defective endothelial cells explain tumor vessel leakiness Am J Pathol 156 2000 1363 1380
135. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
136. L.G. Bajenov, and T.L. Bajenova Regression of malignant tumors with the help of microorganisms and prospect of this phenomenon application in medical practice Proceedings of the second international scientific teleconference on new technology in medicine, vol. 3 2005 111 113
137. K.F. Kolmel, J.M. Grange, and B. Krone Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients Eur J Cancer 41 2005 118 125
138. A. Pfahlberg, K.F. Kolmel, and J.M. Grange Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study J Invest Dermatol 119 2002 570 575
139. B. Krone, K.F. Kolmel, and J.M. Grange Impact of vaccinations and infectious diseases on the risk of melanoma - evaluation of an EORTC case-control study Eur J Cancer 39 2003 2372 2378
140. M. Kondo A bad dose of the 'flu Lancet 362 2003 2122
141. I. Kato, K.L. Koenig, and R.E. Shore Use of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin's lymphoma (NHL) (United States) Cancer Causes Contr 13 2002 965 974
142. J.R. Cerhan, K.E. Anderson, C.A. Janney, C.M. Vachon, T.E. Witzig, and T.M. Habermann Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma Int J Cancer 106 2003 784 788